CS
ZVRA icon

Credit Suisse’s Zevra Therapeutics ZVRA Stock Holding History

Credit Suisse’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16
Closed – – 4342
2022
Q2 		$0 Buy
+16
New +$73 ﹤0.01% 4373
2016
Q3 		– Sell
-647
Closed -$41K – 4285
2016
Q2 		$41K Sell
647
-1,508
-70% -$248K ﹤0.01% 4161
2016
Q1 		$500K Buy
2,155
+1,484
+221% +$359K ﹤0.01% 3237
2015
Q4 		$213K Buy
+671
New +$182K ﹤0.01% 3857

Other funds holding ZVRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $431M AUM 25.35% 1-Year Est. Return